Clinical Trials Directory

Trials / Completed

CompletedNCT02495818

Suprascapular Nerve Block Guided by Ultrasound

Suprascapular Nerve Block Guided by Ultrasound in the Rehabilitation of the Supraspinatus Tendonitis - A Randomized Double Blind Controlled Trial

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
87 (actual)
Sponsor
Marta Imamura · Academic / Other
Sex
All
Age
30 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the effect of suprascapular nerve block guided by ultrasound combined with home exercises compared with placebo. Pain intensity, function, pressure pain threshold and goniometry were designed to be assessed in all patients.

Detailed description

The trial is being carried out in the Institute of Physical Medicine and Rehabilitation of the University of São Paulo since June 2013. The investigators are including patients with clinical diagnosis of supraspinatus tendinitis based on the Lateral Jobe Test. The patients are being randomized in two arms: Active (2% 5ml lidocaine for suprascapular nerve block and home exercises) and placebo control (saline solution as the nerve block and home exercises). The randomization is being performed in blocks of 4 and 6. The investigator, the raters, the MD who makes the procedure and the patients are blind to treatment. 4 visits are being performed. Screening and initial evaluation visit, procedure visit, follow up 1 week after intervention and follow up 12 weeks after intervention. The sample size was estimated to be 54 in each arm.

Conditions

Interventions

TypeNameDescription
PROCEDURELidocaineSuprascapular Nerve Block Guided by Ultrasound with 5ml lidocaine at 2%.
PROCEDURESaline solutionSuprascapular Nerve Block Guided by Ultrasound with 5ml saline solution
OTHERHomemade exercisesCodman and Hughston exercises.

Timeline

Start date
2013-06-01
Primary completion
2017-03-01
Completion
2017-06-01
First posted
2015-07-13
Last updated
2018-05-16

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT02495818. Inclusion in this directory is not an endorsement.